Second sphere complexes as relaxation agents for image enhancement in magnetic resonance imaging
AssigneeThe University of Toledo
InventorJulian A. Davies
Life of this patent
Estimating the term…
Abstract
A second sphere contrast enhancing agent for magnetic resonance imaging comprises a paramagnetic metal ion having catecholate ligands coordinated thereto and having water molecules hydrogen bonded to the catecholate ligands.
Claims12
A second sphere contrast enhancing agent for magnetic resonance imaging of tissue, comprising a highly charged hydrophilic complex having a charge of three minus or greater which consists of a paramagnetic metal ion and at least one 1,2-dihydroxybenzene catecholate ligand coordinated to said paramagnetic metal ion.
A method for performing magnetic resonance imaging of a patient, comprising:
- a) providing a second sphere contrast enhancing agent, comprising a highly charged hydrophilic complex having a charge of three minus or greater which consists of a paramagnetic metal ion and at least one 1,2-dihydroxybenzene catecholate ligands coordinated thereto,
- b) administering the second sphere contrast enhancing agent to the patient;
- c) forming one or more hydrogen bonds between the paramagnetic metal ion-to-ligand linkage and tissue water molecules of the patient;
- and
- d) subjecting the patient to nuclear magnetic resonance imaging.
A second sphere contrast enhancing agent for magnetic resortames imaging of tissue, comprising:
- a) a paramagnetic metal ion selected (III) and gadolinium (III);
- b) at least one 1,2-dihydroxybenzene catecholate ligand coordinated to said paramagnetic metal ion to form a highly charged hydrophilic complex having a charge of three minus or greater, said catecholate ligands prepared from the salt disodium-1,2-dihydroxybenzene-3,5-disulfonate end forming bonding sites for hydrogen bonding where such hydrogen bonding sites include heteroatoms which form paramagnetic metal ion-to-ligand linkages;
- and
- c) water molecules hydrogen bonded to the bonding sites of said catecholate ligands.
Dependencies are inferred from the claim text.